Literature DB >> 28905364

A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.

Anaïs Winchenne1, Jérôme Cecchini1,2, Jean-François Deux3, Nicolas De Prost1,2, Keyvan Razazi1,2, Guillaume Carteaux1,2, Frederic Galacteros4,5, Anoosha Habibi4,5, Pablo Bartolucci4,5, Giovanna Melica6, Mehdi Khellaf5,7, Marc Michel8, Bernard Maitre2,9, Armand Mekontso Dessap1.   

Abstract

Pulmonary artery thrombosis (PAT) is involved in lung vascular dysfunction during acute chest syndrome (ACS) complicating sickle cell disease (SCD). No clinical score is available to identify patients eligible for multi-detector computed tomography (MDCT) angiography during ACS. This retrospective study aimed to develop a risk score for PAT during ACS (PAT-ACS risk score). Patients with SCD were investigated by MDCT during ACS. A logistic regression was performed to determine independent risks factors for PAT and to build the PAT-ACS risk score. A total of 43 episodes (11·9%) of PAT were diagnosed in 361 episodes of ACS. Multivariate analysis identified four risk factors, which were included in the PAT-ACS risk score: a baseline haemoglobin >82 g/l, the lack of a triggering factor for ACS, a platelet count >440 × 109 /l and a PaCO2 <38 mmHg at ACS diagnosis. The area under the receiver operating characteristic curve for the PAT-ACS risk score was 0·74 (95% confidence interval [CI] 0·69-0·79) and differed from that of the revised Geneva score (0·63 (95% CI 0·58-0·69); P = 0·04). The negative predictive value of a PAT-ACS risk score ≥2 was 94%. In conclusion, we propose a simple clinical risk score to identify SCD patients at high risk of PAT during ACS.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute chest syndrome; multidetector computed tomography; pulmonary artery thrombosis; sickle cell disease; sickle cell disease complications

Mesh:

Substances:

Year:  2017        PMID: 28905364     DOI: 10.1111/bjh.14914

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  1 in total

1.  Confirmation of the utility of the Wells' Score for pulmonary embolism in patients with sickle cell disease.

Authors:  Jori E May; Steven D Lauzon; Richard C Godby; Julie Kanter
Journal:  J Thromb Thrombolysis       Date:  2022-04-19       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.